vs
MACROGENICS INC（MGNX）与RMR GROUP INC.（RMR）财务数据对比。点击上方公司名可切换其他公司
RMR GROUP INC.的季度营收约是MACROGENICS INC的1.6倍（$66.7M vs $41.2M），MACROGENICS INC同比增速更快（113.0% vs 40.8%）
MacroGenics Inc是一家临床阶段生物制药公司，专注于研发针对癌症和自身免疫性疾病的新型免疫疗法，核心产品管线以单克隆抗体类治疗药物为核心，重点项目覆盖实体瘤与血液恶性肿瘤，通过与全球药企合作推进产品落地。
RMR集团是总部位于美国的另类资产管理企业，核心业务聚焦不动产及相关投资，覆盖商业地产、住宅物业、基础设施等赛道，服务全球核心市场的机构投资者、高净值人士及零售客户。
MGNX vs RMR — 直观对比
营收规模更大
RMR
是对方的1.6倍
$41.2M
营收增速更快
MGNX
高出72.3%
40.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $41.2M | $66.7M |
| 净利润 | — | $12.2M |
| 毛利率 | — | — |
| 营业利润率 | -29.3% | 48.1% |
| 净利率 | — | 18.3% |
| 营收同比 | 113.0% | 40.8% |
| 净利润同比 | — | 91.1% |
| 每股收益（稀释后） | $-0.23 | $0.71 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MGNXRMR
| Q4 25 | $41.2M | $66.7M | ||
| Q3 25 | $72.8M | — | ||
| Q2 25 | $22.2M | — | ||
| Q1 25 | $13.2M | — | ||
| Q4 24 | $19.4M | — | ||
| Q3 24 | $110.7M | — | ||
| Q2 24 | $10.8M | — | ||
| Q1 24 | $9.1M | — |
净利润MGNXRMR
| Q4 25 | — | $12.2M | ||
| Q3 25 | $16.8M | — | ||
| Q2 25 | $-36.3M | — | ||
| Q1 25 | $-41.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $56.3M | — | ||
| Q2 24 | $-55.7M | — | ||
| Q1 24 | $-52.2M | — |
毛利率MGNXRMR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 98.8% | — | ||
| Q3 24 | 99.8% | — | ||
| Q2 24 | 98.4% | — | ||
| Q1 24 | 97.0% | — |
营业利润率MGNXRMR
| Q4 25 | -29.3% | 48.1% | ||
| Q3 25 | 25.6% | — | ||
| Q2 25 | -165.3% | — | ||
| Q1 25 | -323.1% | — | ||
| Q4 24 | -273.0% | — | ||
| Q3 24 | 48.9% | — | ||
| Q2 24 | -538.9% | — | ||
| Q1 24 | -590.4% | — |
净利率MGNXRMR
| Q4 25 | — | 18.3% | ||
| Q3 25 | 23.1% | — | ||
| Q2 25 | -163.0% | — | ||
| Q1 25 | -311.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 50.9% | — | ||
| Q2 24 | -515.6% | — | ||
| Q1 24 | -573.3% | — |
每股收益（稀释后）MGNXRMR
| Q4 25 | $-0.23 | $0.71 | ||
| Q3 25 | $0.27 | — | ||
| Q2 25 | $-0.57 | — | ||
| Q1 25 | $-0.65 | — | ||
| Q4 24 | $-0.24 | — | ||
| Q3 24 | $0.90 | — | ||
| Q2 24 | $-0.89 | — | ||
| Q1 24 | $-0.84 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $57.2M | $49.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $55.6M | $232.7M |
| 总资产 | $256.8M | $687.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MGNXRMR
| Q4 25 | $57.2M | $49.3M | ||
| Q3 25 | $80.1M | — | ||
| Q2 25 | $130.7M | — | ||
| Q1 25 | $145.6M | — | ||
| Q4 24 | $182.8M | — | ||
| Q3 24 | $179.6M | — | ||
| Q2 24 | $83.9M | — | ||
| Q1 24 | $80.4M | — |
股东权益MGNXRMR
| Q4 25 | $55.6M | $232.7M | ||
| Q3 25 | $67.0M | — | ||
| Q2 25 | $46.6M | — | ||
| Q1 25 | $79.1M | — | ||
| Q4 24 | $116.1M | — | ||
| Q3 24 | $120.1M | — | ||
| Q2 24 | $57.8M | — | ||
| Q1 24 | $106.2M | — |
总资产MGNXRMR
| Q4 25 | $256.8M | $687.1M | ||
| Q3 25 | $270.8M | — | ||
| Q2 25 | $245.4M | — | ||
| Q1 25 | $224.6M | — | ||
| Q4 24 | $261.7M | — | ||
| Q3 24 | $264.5M | — | ||
| Q2 24 | $201.1M | — | ||
| Q1 24 | $248.3M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $43.0M | $10.7M |
| 自由现金流经营现金流 - 资本支出 | $42.8M | — |
| 自由现金流率自由现金流/营收 | 103.8% | — |
| 资本支出强度资本支出/营收 | 0.6% | — |
| 现金转化率经营现金流/净利润 | — | 0.88× |
| 过去12个月自由现金流最近4个季度 | $-83.0M | — |
8季度趋势，按日历期对齐
经营现金流MGNXRMR
| Q4 25 | $43.0M | $10.7M | ||
| Q3 25 | $-30.2M | — | ||
| Q2 25 | $-47.0M | — | ||
| Q1 25 | $-46.9M | — | ||
| Q4 24 | $-38.4M | — | ||
| Q3 24 | $60.2M | — | ||
| Q2 24 | $-44.5M | — | ||
| Q1 24 | $-45.6M | — |
自由现金流MGNXRMR
| Q4 25 | $42.8M | — | ||
| Q3 25 | $-30.6M | — | ||
| Q2 25 | $-47.7M | — | ||
| Q1 25 | $-47.4M | — | ||
| Q4 24 | $-39.0M | — | ||
| Q3 24 | $59.6M | — | ||
| Q2 24 | $-45.5M | — | ||
| Q1 24 | $-47.1M | — |
自由现金流率MGNXRMR
| Q4 25 | 103.8% | — | ||
| Q3 25 | -42.0% | — | ||
| Q2 25 | -214.5% | — | ||
| Q1 25 | -359.5% | — | ||
| Q4 24 | -201.7% | — | ||
| Q3 24 | 53.8% | — | ||
| Q2 24 | -421.6% | — | ||
| Q1 24 | -517.4% | — |
资本支出强度MGNXRMR
| Q4 25 | 0.6% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | 3.2% | — | ||
| Q1 25 | 4.0% | — | ||
| Q4 24 | 3.2% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 9.6% | — | ||
| Q1 24 | 16.0% | — |
现金转化率MGNXRMR
| Q4 25 | — | 0.88× | ||
| Q3 25 | -1.79× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.07× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MGNX
| Revenue From Collaborative Agreements | $20.3M | 49% |
| Contract Manufacturing | $11.3M | 27% |
| Other | $9.7M | 23% |
RMR
| Management Service Incentive | $23.6M | 35% |
| Industrial Logistics Properties Trust | $15.1M | 23% |
| Managed Private Real Estate Capital | $11.1M | 17% |
| Office Properties Income Trust | $5.6M | 8% |
| Other Private Entities | $5.3M | 8% |
| RMR Residential | $3.4M | 5% |
| Sonesta International Hotels Corporation | $2.1M | 3% |
| Investment Advisory Management And Administrative Service | $1.2M | 2% |
